SH2B1 and non-small cell lung carcinoma: Importantly, NSCLC cells proliferation was increased in S2B1 over-expression cell (H1299-SH2B1), while the proliferation effect was dramatically impaired by deguelin (Fig. 4c) and mTORC1 inhibitor rapamycin (Additional file 1: Figure S2).